CorMedix Inc (NASDAQ: CRMD) stock closed at $4.91 on 7/11/24 after a major increase of 10.3%. Moreover, this advance was accompanied by above average trading volume at 137% of normal. The stock has been exceptionally strong relative to the market over the last nine months and has risen 19.2% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, CRMD is expected to continue to be Value Creation neutral.
CorMedix has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. CorMedix has a very low Appreciation Score of 4 but a very high Power Rating of 93, resulting in the Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment